Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents

NCT01574235 · clinicaltrials.gov ↗

COMPLETED

Status

2114

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors
Malignant Hemopathy
Chemotherapy-induced Febrile Neutropenia (FN)

Interventions

BIOLOGICAL: Nivestim®

Sponsor

Hospira, now a wholly owned subsidiary of Pfizer